The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the two essential elements that should merge into an integrated workflow for modelers and chemists to allow experiments to concentrate on the most promising molecules.
SOM Biotech uses a proprietary cutting-edge in silico platform together with various other computational tools -including the Schrödinger software- to identify new treatments for orphan diseases. As Luca Signorile highlights, “sharing knowledge with the most advanced scientific teams and taking advantage of the most advanced technologies will undoubtedly contribute to boost drug discovery and its efficacy. Our efforts aim at reducing the costs and the time needed to bring medicines to patients”.
At SOM BIOTECH we use our own and third-party cookies to analyze the use made by users of the website to improve our services. For more information, please, check our cookies policy.
En SOM BIOTECH utilizamos cookies propias y de terceros para analizar el uso que hacen los usuarios del sitio web para mejorar nuestros servicios. Para más información, consulte nuestra política de cookies.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.